Most of the CNAs identified in CRC were either amplification of oncogenes or deletion of tumor suppressor genes, such as MYC. The prevalence of MYC amplification of 8% to 25% was observed in several studies [133,134]. Here, MYC is linked to colorectal carcinoma.